↓ Skip to main content

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines

Overview of attention for article published in BMC Health Services Research, November 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
81 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
Published in
BMC Health Services Research, November 2019
DOI 10.1186/s12913-019-4715-8
Pubmed ID
Authors

Anne Julienne Genuino, Usa Chaikledkaew, Anna Melissa Guerrero, Thanyanan Reungwetwattana, Ammarin Thakkinstian

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 81 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 12%
Student > Bachelor 9 11%
Researcher 7 9%
Lecturer 6 7%
Unspecified 5 6%
Other 18 22%
Unknown 26 32%
Readers by discipline Count As %
Medicine and Dentistry 18 22%
Pharmacology, Toxicology and Pharmaceutical Science 11 14%
Nursing and Health Professions 7 9%
Unspecified 5 6%
Economics, Econometrics and Finance 4 5%
Other 11 14%
Unknown 25 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2022.
All research outputs
#3,179,538
of 24,875,365 outputs
Outputs from BMC Health Services Research
#1,411
of 8,413 outputs
Outputs of similar age
#72,146
of 469,547 outputs
Outputs of similar age from BMC Health Services Research
#50
of 231 outputs
Altmetric has tracked 24,875,365 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,413 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 469,547 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 231 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.